Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mauvais-Jarvis, F.
Right arrow Articles by Kahn, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauvais-Jarvis, F.
Right arrow Articles by Kahn, C. R.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 12 2126-2134, Copyright © 2000 by American Diabetes Association

ARTICLES

A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes

F Mauvais-Jarvis, A Virkamaki, MD Michael, JN Winnay, A Zisman, RN Kulkarni and CR Kahn
Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA.

Type 2 diabetes is a polygenic disease characterized by defects in both insulin secretion and insulin action. We have previously reported that isolated insulin resistance in muscle by a tissue-specific insulin receptor knockout (MIRKO mouse) is not sufficient to alter glucose homeostasis, whereas beta-cell-specific insulin receptor knockout (betaIRKO) mice manifest severe progressive glucose intolerance due to loss of glucose-stimulated acute-phase insulin release. To explore the interaction between insulin resistance in muscle and altered insulin secretion, we created a double tissue-specific insulin receptor knockout in these tissues. Surprisingly, betaIRKO-MIRKO mice show an improvement rather than a deterioration of glucose tolerance when compared to betaIRKO mice. This is due to improved glucose-stimulated acute insulin release and redistribution of substrates with increased glucose uptake in adipose tissue and liver in vivo, without a significant decrease in muscle glucose uptake. Thus, insulin resistance in muscle leads to improved glucose-stimulated first-phase insulin secretion from beta-cells and shunting of substrates to nonmuscle tissues, collectively leading to improved glucose tolerance. These data suggest that muscle, either via changes in substrate availability or by acting as an endocrine tissue, communicates with and regulates insulin sensitivity in other tissues.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Tiwari, S. Riazi, and C. A. Ecelbarger
Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F974 - F984.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Le May, K. Chu, M. Hu, C. S. Ortega, E. R. Simpson, K. S. Korach, M.-J. Tsai, and F. Mauvais-Jarvis
Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice
PNAS, June 13, 2006; 103(24): 9232 - 9237.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. A. Pederson, J. M. Schroeder, G. E. Parker, M. W. Smith, A. A. DePaoli-Roach, and P. J. Roach
Glucose Metabolism in Mice Lacking Muscle Glycogen Synthase
Diabetes, December 1, 2005; 54(12): 3466 - 3473.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. Watson, S. Hahm, T. M. Mizuno, J. Windsor, C. Montgomery, P. E. Scherer, C. V. Mobbs, and S. R. J. Salton
VGF Ablation Blocks the Development of Hyperinsulinemia and Hyperglycemia in Several Mouse Models of Obesity
Endocrinology, December 1, 2005; 146(12): 5151 - 5163.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Ohsugi, C. Cras-Meneur, Y. Zhou, E. Bernal-Mizrachi, J. D. Johnson, D. S. Luciani, K. S. Polonsky, and M. A. Permutt
Reduced Expression of the Insulin Receptor in Mouse Insulinoma (MIN6) Cells Reveals Multiple Roles of Insulin Signaling in Gene Expression, Proliferation, Insulin Content, and Secretion
J. Biol. Chem., February 11, 2005; 280(6): 4992 - 5003.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Dela, M. E. von Linstow, K. J. Mikines, and H. Galbo
Physical training may enhance {beta}-cell function in type 2 diabetes
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E1024 - E1031.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. J. Goren, R. N. Kulkarni, and C. R. Kahn
Glucose Homeostasis and Tissue Transcript Content of Insulin Signaling Intermediates in Four Inbred Strains of Mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1
Endocrinology, July 1, 2004; 145(7): 3307 - 3323.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Cariou, C. Postic, P. Boudou, R. Burcelin, C. R. Kahn, J. Girard, A.-F. Burnol, and F. Mauvais-Jarvis
Cellular and Molecular Mechanisms of Adipose Tissue Plasticity in Muscle Insulin Receptor Knockout Mice
Endocrinology, April 1, 2004; 145(4): 1926 - 1932.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. N. Bergman, M. Ader, K. Huecking, and G. Van Citters
Accurate Assessment of {beta}-Cell Function: The Hyperbolic Correction
Diabetes, February 1, 2002; 51(90001): S212 - 220.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.